Intel Corporation (INTC)

By both methods, the value today (DCF $29 · Multiples $41) is below the market price ($101).

Today — expensive, no margin of safety: at $101 trades ~147.2% above its value discounted to today (~$41); the expected return does not even reach the risk-free rate (4.5%).

At 5 years — Sobrevalorado: the expected total return is negative — the price already discounts a demanding scenario that, if not met, results in a loss.

The bridge: the return at 5 years falls below the risk-free rate (4.5%) — which is why there is not even a discount to today's value. To require a 15% annual return, it would need to be bought at ~$25.

Educational / informational. Does not constitute investment advice.

The inverse approach: instead of projecting growth to obtain the value, the market price ($101) is taken as given and it solves for what annual owner-earnings growth would need to hold for 5 years for the present value —at the method's rate (4.5%, no-growth terminal)— to equal that price. It is the disconfirmation test: the expectations the price already pays for, contrasted against the method's projection.

The price discounts growth (45.7%/year) above our base case (14.0%/year) → it is priced for a demanding scenario and leaves little cushion against a slowdown.

That growth implies ~$26.7 bn of owner earnings in year 5 (vs ~$7.8 bn of our base case). It recalculates if the DCF assumptions are edited.

Year-by-year projection of the selected scenario. From each year, two versions of the flow are derived: growth FCF (operating flow − total capex, the cash surplus) and maintenance FCF (the owner earnings: what the business yields if it only sustains its capacity). The flow is returned almost in full (dividend + buyback) or redeployed into the operation, so that EV stays roughly flat and multiples compress because the metric grows, not because of cash accumulation. The valuation is done on EV/NOPAT. In edit mode, revenue, margins, capex, and exit multiples can be adjusted.

It is valued on EV/NOPAT, the metric of the semiconductor archetype, and for a reason that is decisive at this company: net income for the last twelve months (−US$11.29bn) is dominated by a non-cash, non-operating charge of US$15,415M from marking to market the shares pledged under the agreement with the US government (US$1,796M in 2025 plus US$13,619M in the first half of 2026, cash flow statement), and by the prior pre-tax gain of US$5.6bn from the sale of 51% of Altera, which the release itself classifies within «interest and other, net». Both items live below operating income: valuing on NOPAT leaves them out and additionally expenses stock-based compensation (US$2.39bn over twelve months, 84.5% of free cash flow), exactly as the method requires when that compensation is material against the flow. The 11% tax rate is not an assumption: it is the long-term projected rate the company itself publishes for 2026 in its release reconciliation (12% for 2025), built on its own five-year projection; the accounting effective rate from XBRL (98.3% in 2025, negative in other years) is an artifact of impairments and of the valuation allowance on deferred tax assets. The year-0 operating margin is the normalized last-twelve-month figure, and the normalization comes from levels presented on a single basis (the cash flow statement), not from an assumption: the reported result of −US$0.08bn carries US$4,061M of restructuring charges in the window (US$3,967M from the half ended 27-Jun-2026 plus US$476M from the first half of 2025 less US$382M from that same half), which return a normalized operating result of US$3.98bn and a 7.0% margin. The US$950M of accelerated depreciation from 2025 is left undeducted because the filing does not allocate it by half and estimating the split would be inventing. Year 1 is anchored to what the company has already reported and guided —a GAAP operating margin of 11.1% in Q2 2026 and a guided gross margin of 41.0% for Q3 2026—, so the margin path is trough-and-recovery and not a monotonic deterioration. Year-1 revenue comes from the level guided for Q3 2026 (midpoint US$16.3bn) annualized with modest sequential progress, not from the historical trajectory: guidance governs over the trend and is also already free of Altera, deconsolidated on 12-Sep-2025. Cash stays stable because the company redeploys its entire surplus into capacity —the chief financial officer announces increased investment in equipment, clean rooms and substrates— and pays no dividend and repurchases no shares since 2024; the proceeds of the August 2026 share issuance are incorporated as excess cash in the bridge, not as operating redeployment.

Today's elevated multiple is the price of growth: if the business grows, the entry point cheapens on its own going forward (the metric grows while EV stays roughly flat). The exit multiple at 3 years is higher than the terminal at 5 years —at 3 years there is more growth still ahead—, so the value curve shows whether value creation is concentrated in the early or the later years. The required return is applied to the base scenario.

They are valued separately, with their own rationale, and are not incorporated into the base or the verdict (they are excess return). When assigning them value — in Editmode —, the total with optionalities updates live, without moving the base.

The verdict, the base CAGR, and the margin of safety are always calculated on the base; optionalities do not alter them (with optionalities at $0 they do not move).

Each card fixes a required annual return and answers: if the business is worth $51 in 5 years, what is the maximum that can be paid today to obtain that return? Since it now trades at $101, the margin of safety is how much cheaper the market is than that maximum. The three thresholds: 4% covers inflation (the floor), 10% is the long-term average return, and 15% is the level of a great investment.

With a target price of $51 in 5 years and a required return of 4.5% annually, the maximum to pay today is $41. Against the current market price ($101), the margin of safety is -147.2% (trades above the maximum → a premium is paid) and the total return at that price would be -12.8% annually.

• Entry multiple. At $101 market capitalization exceeds half a trillion dollars on last-twelve-months normalized operating income of $3.98bn.
• Exit multiple. The blend of the three pieces falls within the semiconductor archetype's band, just above the floor, given the return on capital and the narrowing moat.
• Estimated return. -13% annually in the base case, against a 4% floor that barely preserves nominal capital.
• Favorable scenario. -13% annually: even with 23.5% margins at year five, today's price is just barely matched.
• Second lens. The discounted cash flow on normalized owner earnings converges with the sum of the parts, well below the trading price.
• Dividend yield. Zero: the dividend has been suspended since 2024, so the entire return depends on price.

Each margin over sales, year by year: historical (solid line) → projection (dotted).

• ✕ ROIC exceeds the cost of capital (~10%)
• ✓ CFROIC backs up the ROIC (115%, cash vs. accruals)
• ✓ Healthy balance sheet (low corporate debt)
• ✓ Durable competitive moat (multiple advantages)

• Return on capital. NOPAT of 3.3% on $108.4bn of invested capital with the restructuring-normalized result; even annualizing the most recent quarter on a NOPAT basis it comes to 5.9%, below the 10% bar.
• Cash generation. $14.9bn of operating cash flow over twelve months against $12.1bn of capital expenditures: free cash flow turned positive again after two very negative years.
• Predictability. Four consecutive fiscal years with material extraordinary charges: impairments, restructurings, a tax valuation allowance and mark-to-market adjustments.
• Stock-based compensation. $2.39bn annually, 4.2% of revenue but 84.5% of free cash flow; it is expensed in the metric when valuing on NOPAT.
• Capital intensity. $105.7bn of net plant and equipment to generate $57bn of revenue: the business consumes capital before it returns it.

Annual levels from the official filing (10-K); the % over each bar is the year-over-year (YoY) growth vs the prior year.

Intel's engine reads as volume times price in two distinct markets: in client, laptop and desktop units against average price (flat in 2025); in data center, server volume (+9% in 2025) against average price (-4% on competitive pressure and mix toward lower core-count products). Manufacturing does not read by revenue but by node utilization: its billings are almost entirely internal, and what decides its value is whether the Intel 14A node lands a significant external customer. Capital spending fell from $25.8bn in 2023 to $14.6bn in 2025 and the company states it is rising again.

The % are the annual (year-over-year) growth: each year —historical and projected— vs the prior one; the TTM (trailing 12m) vs the TTM of a year ago, to avoid overlapping windows. The historicals are exact figures from the official filings; the projected years come from the year-by-year model (the intermediate years without their own series are interpolated between the anchors). The projected columns (+1y…+5y) are 12-month windows counted from the TTM close (27-jun-2026): the projection starts from the most recently reported data, not the fiscal year. The projected base is realistic and unbiased — the risk discount is applied at the end, via the required return. The rationale for each metric is in the (i).

• Recent growth. +7.5% over the last twelve months and +25% in the most recent quarter, after three years of contraction.
• Data center. +59% year over year in the 2nd quarter of 2026, driven by demand for artificial intelligence compute.
• Current guidance. $15.8-16.8bn of revenue for Q3 2026, above the prior quarter: the year-1 path anchors there.
• Reinvestment runway. Idle installed capacity exists, but its return depends on landing external customers that have not yet materialized.
• Artificial intelligence accelerators. The company acknowledges failing to become a relevant player; Gaudi inventory charges were $375M in 2025.
• Terminal growth. The path reaches a mid-single digit by year five, consistent with a mature market and intensifying competition.

• Ten-year relevance. General-purpose compute is not going away and Intel is one of three players capable of manufacturing it at leading-edge nodes.
• Differentiated product. In client, differentiation is eroding against AMD and ARM; in manufacturing, Intel 18A is genuinely leading-edge.
• Market share. The company states in its annual report that it has lost share in client and in data center within x86.
• Pricing power. Average server prices fell 4% in 2025 and client prices were flat: price is not a lever.
• Operating leverage. Very high and double-edged: gross margin rose 12.9 percentage points in a quarter on yields and volume, and can reverse just as fast.
• Recession behavior. Revenue fell 14% in 2023 and operating income reached -$11.7bn in 2024: the business is cyclical and carries heavy fixed costs.

Not all debt is equal: only the structural needs refinancing; the rest is operational (self-liquidating).

Structural debt is what is exposed to the contraction phase of the cycle; operational debt (leases, matched funding) self-liquidates with the business.

• !Leverage (net debt / EBITDA)Net debt / EBITDA 1.3x
• !Interest coverage (EBIT / interest)3.7x
• –Liquidity (current ratio)no data
• ✓Cash quality (CFROIC vs ROIC)CFROIC backs 115% of ROIC
• ✕Value creation (ROIC − 10% bar)-7pp
• ✓Malinvestment test (capex vs incremental ROIC)Capex/D&A 1.0x — no over-investment
• !Float / working capitalConsumes cash $1.6 bn (positive WC)
• !Dilution (SBC % of revenue + shares)SBC 4.2% of revenue

A traffic-light interpreted by the method (not generic): float (negative WC) adds up, capex is judged by incremental ROIC (malinvestment test), and a lender is not subjected to corporate solvency. The (i) shows the derivation of each number.

• Net debt. Net cash position of about $1.9bn after the August 2026 share issuance ($50.5bn of debt against about $52.4bn of cash and short-term investments).
• Coverage. With normalized operating income at $3.98bn and interest expense of $1.09bn in 2025 (net of $1.2bn capitalized), coverage is approximately 3.7 times on the normalized result and negative on reported operating income (-$0.08bn); it is supported, in any case, by operating cash flow of $14.9bn.
• Liquidity. $57.2bn of current assets against $35.7bn of current liabilities as of Jun 27, 2026.
• Assets. $105.7bn of net plant and equipment and $20.5bn of goodwill, versus $23.9bn at the close of 2025; the incorporated material does not include the Q2 2026 10-Q note explaining the $3.4bn change, so the balance change is disclosed without attributing a cause.
• Access to financing. Debt grew from $46.6bn to $50.5bn during the half-year and there are co-investors in the fabs (Brookfield, Apollo) with associated conditions.

How cash comes in and how it is deployed. In green, the business's own cash (the owner-FCF it generates and reinvests); in gray, the float and credit — customer and funding money, which is not the shareholder's.

All capital goes to the fab: $12.1bn of capital expenditures over the last twelve months, plus an announced investment of €5,000 million to expand Xeon 6 capacity on Intel 3. There has been no dividend since 2024 and no buybacks since 2021, and the acquisitions portion is marginal ($596M in the first half of 2026). The other side of the funding picture is that the surplus is not enough: the company funded itself with additional debt, with the sale of Altera, with the acceleration of the CHIPS agreement, and with a $23,000M gross share issuance in August 2026, which explains why the share count went from 4,123 million in 2022 to roughly 5,346 million.

Who owns the shares — the alignment and whether there is a controlling shareholder.

• Restructuring execution. Headcount reduction of nearly 15%, research spending from $16.5bn to $13.8bn, and sale of 51% of Altera for $4.3bn net.
• Roadmap execution. Intel 18A entered high-volume manufacturing and 18A-P entered risk production within the committed schedule.
• Shareholder dilution. The share count went from 4,123 million in 2022 to roughly 5,346 million after the issuance of 242.1 million shares in August 2026 at $95.00 (~$23,000M gross); the government's warrant for 241 million remains contingent and the company does not expect it to become exercisable.
• Shareholder returns. Dividend suspended since 2024 and no buybacks since 2021: all cash flow goes to the fab.
• Candor of the report. The annual report clearly acknowledges the loss of share and the failure in accelerators, without dressing up the diagnosis.

• The stock rose sharply, driven by the narrative of compute demand for artificial intelligence and by the quarter with the largest growth in more than fifteen years.
• The U.S. government's stake, the conversion of CHIPS program subsidies into shares and the Secure Enclave agreement instilled the perception of public backing that reduces tail risk.
• The market extrapolates the 2nd-quarter's 12.9-percentage-point gross margin expansion and the 59% data center growth, over a twelve-month base that still earns close to zero in operating income.
• Intel 18A entered high-volume manufacturing on the committed schedule and 18A-P entered risk production, validating the process roadmap for the first time in years.

There are no missing buyers or motivated sellers to identify: the stock is not discounted, it is priced at a premium. The right question is why the market pays this price, and the answer is that it capitalizes the full execution of the recovery — 2019 margins on 2030 revenue — before it is proven. The method itself warns that a high multiple is justified only if the business keeps compounding by the end of the horizon; here the base case already assumes 17% operating margins at year five and the return is still negative.

The annual return (CAGR at 5 years) in each scenario, with the total period return below — the margin of safety made visual: upside range wide, downside range narrow.

Even in the bear scenario, the return holds at -34%/year (-87% total): the margin of safety protects the downside. The bull (+2%/year, +11% total) exceeds it comfortably — a favorable asymmetry, with a narrow downside range and a wide upside range.

• Conditionality of the 14A node. Without a significant external customer, the company warns it may pause development of subsequent nodes, with impairments on more than $100bn of assets.
• Structural competition. AMD within x86, ARM in client and cloud, in-house silicon from the major cloud providers, and NVIDIA capturing artificial intelligence spending.
• State shareholder. The U.S. government's stake dilutes, reduces the voting rights of the rest, and may expose the international business to restrictions.
• Geographic concentration. 24% of revenue is billed to China, the Israel fab is not insured against conflict-related disruptions, and ASML is the sole supplier of extreme ultraviolet lithography.
• Product defects. The instability of the 13th- and 14th-generation desktop processors affected 2024 volume and may raise warranty costs.

Each thinker's analytical framework applied to our data.

• Buffett / Graham Quality + margin of safety

  Fails the quality gate: narrow moat, eroding.

• Peter Lynch Growth at a reasonable price (GARP)

  A fast grower growing 14% at a multiple/growth of 10.8 → expensive for its growth.

• Joel Greenblatt Cheap and high-return (Magic Formula)

  Earnings yield 1% (EBIT/EV) + ROIC 3% → falls outside the Magic Formula.

• Howard Marks Perception vs reality + cycle

  The price discounts 46% vs our 14%: priced for perfection, no favorable mispricing.

• Seth Klarman Capital protection (bear scenario)

  Bear-scenario floor -34%/yr over 5y (material loss) → risk of permanent capital loss.

• Pat Dorsey Moat strength (Five Rules)

  A narrow moat, eroding; sources: switching costs, efficient scale, intangibles → fails the Five Rules.

• Aswath Damodaran Expectations implied by the price

  The price demands 46% growth, far above our 14% — heroic assumptions.